Same medicine. Same results.
Lower cost.
  • Biosimilars

    Biosimilars

    GPhA applauds Congress for establishing an abbreviated...
  • Drug Shortages

    As members of the public who also are affected by...
  • Quality

    Science and quality are the cornerstones of the generic...
  • Patent Settlements

    Patent Settlements

    GPhA vigorously opposes restricting the right of parties in...
  • GDUFA

    GPhA and its member companies support full implementation...
 

Improving Lives for Less

New data from the 2013 Generic Drug Savings in the U.S. report shows that generic pharmaceuticals saved the U.S. health system and patients $217 billion in 2012. That’s $1.3 trillion dollars in the most recent decade. In 2012 alone, savings for the retail markets totaled $171 billion. Generics have saved out-of-pocket cash payers $78 billion over the past 10 years – these typically are the uninsured and poorer customers. All data were compiled by IMS Health on behalf of GPhA.   learn more >

Value and Quality

2013 Annual Report

The 2013 Annual Report is now available. GPhA furthers the industry’s goal to improve the lives of consumers by providing timely access to high quality, affordable medicine. Together, we continue to drive value and quality for patients. learn more >